Investors States Shareholder Requisition of Special Meeting
to Effect Significant Change to the Board May be Necessary
SHERIDAN, Wyo., Sept. 28,
2022 /PRNewswire/ -- Today, FCM MM HOLDINGS, LLC
("FCM") announces that it has sent a letter (the "Letter") to the
Board of Directors (the "Board") of Mind Medicine (MindMed) Inc.
(NASDAQ: MNMD) ("MindMed" or the "Company") informing the Board of
FCM's vehement opposition to the Company's public offering
announced on September 27, 2022 (the
"Dilutive Offering"). In the Letter, FCM details how the Board's
and management's actions, including the Dilutive Offering, have
destroyed shareholder value, calls for the Board to immediately
terminate the offering, and pledges to take action to hold the
Board accountable.
"We are committed to taking whatever
actions are necessary to protect the interest of
shareholders"
"We are committed to taking whatever actions are necessary to
protect the interest of shareholders, and we look forward to
engaging in a zealous proxy campaign" said FCM Chief Executive
Manager Jake Freeman.
The full text of the letter is available and can be downloaded
at mindmed.zone/letterdilution
About FCM
FCM is managed by Jake Freeman
and represents an investment of 6.1% of MindMed's shares
outstanding.
FCM additionally represents other early investors in MindMed,
including Scott Freeman and
Chad Boulanger, who all have a
strong interest in seeing the long-term success of MindMed.
For additional disclosure relating to public broadcast
solicitations please see mindmed.zone/disclosure
Media Contact
Jake
Freeman
Chief Executive Manager
FCM MM HOLDINGS, LLC
30 N Gould St. Ste R
Sheridan, WY 82801
Phone: 908-308-2381
Email: jake@mindmed.zone
View original
content:https://www.prnewswire.com/news-releases/mindmed-board-is-trippin-significant-investor-calls-for-termination-of-highly-dilutive-equity-offering-and-pledges-to-hold-board-and-management-accountable-through-activist-campaign-301636059.html
SOURCE FCM MM Holdings, LLC